Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency
Public ClinicalTrials.gov record NCT07385547. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of GL0034
Study identification
- NCT ID
- NCT07385547
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Sun Pharmaceutical Industries Limited
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- GL0034 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 24, 2026
- Primary completion
- Aug 31, 2026
- Completion
- Sep 26, 2026
- Last update posted
- Mar 12, 2026
2026
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Syneos Miami | Miami | Florida | 33136 | Not yet recruiting |
| Panax Clinical Research | Miami Lakes | Florida | 33014 | Recruiting |
| Orlando Clinical Research Center (OCRC) | Orlando | Florida | 32809 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07385547, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07385547 live on ClinicalTrials.gov.